Does plasmapheresis desensitize kidney transplant recipients more effectively than high-dose immunoglobulin?
Suphamai Bunnapradist
Correspondence David Geffen School of Medicine, Department of Medicine, Division of Nephrology, Kidney, and Pancreas Transplant Research Office, 924 Westwood Boulevard, Suite 860, Los Angeles, CA 90095-7306, USA
Email bunnapradist@mednet.ucla.edu
This article has no abstract so we have provided the first paragraph of the full text.
Sensitization (the presence of preformed antibodies against human leukocyte antigen [HLA] in the blood) is a major barrier to successful kidney transplantation.1 In recent years, many therapeutic approaches have been developed for the reduction or removal of HLA antibodies. Two such 'desensitization' protocols have been used successfully: high-dose IVIG, and plasmapheresis plus low-dose IVIG.2, 3
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
